Dr Mary Elizabeth Metschke, DDS | |
102 N Park St, Chambers, NE 68725-0269 | |
(402) 482-5466 | |
Not Available |
Full Name | Dr Mary Elizabeth Metschke |
---|---|
Gender | Female |
Speciality | Dentist |
Location | 102 N Park St, Chambers, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164568754 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | 6663 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mary Elizabeth Metschke, DDS Po Box 269, 102 N Park St., Chambers, NE 68725-0269 Ph: (402) 482-5466 | Dr Mary Elizabeth Metschke, DDS 102 N Park St, Chambers, NE 68725-0269 Ph: (402) 482-5466 |
News Archive
According to New Study Published in The American Journal of Medicine, there is burgeoning public interest in possible wide-ranging health benefits from vitamin D, including cardiovascular health.
Teacher well-being, efficacy, burnout-related stress, time-related stress and mindfulness significantly improve when teachers participate in the CARE (Cultivating Awareness and Resilience in Education) for Teachers program, according to Penn State researchers.
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
The American Epilepsy Society announces that Brian Litt, M.D., professor of neurology, neurosurgery and bioengineering at the University of Pennsylvania, is being honored with the AES Research Recognition Award for Clinical Science on December 7, 2015, at the Society's 69th annual meeting in Philadelphia.
› Verified 3 days ago